Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,461 total articles
I-80 Gold is a Nevada-focused gold company with a pipeline of near-term production and low-cost assets. Shares appear to be pricing in little of the company’s development optionality. This trade idea lays out a mid-term, actionable long with concrete entry, stop and target, and a clear risk framework.
Alphabet ($323.31) is a pragmatic way to capture AI’s upside without betting on raw infrastructure plays. The company pairs dominant consumer endpoints (Search, YouTube, Play) with profitable cloud contracts and a low-debt balance sheet. I propose a long trade with entry at $323.31, target $380.00 and stop loss $295.00 over a 180 trading day horizo…
CoreWeave’s growth story is intact, but financing risk and negative cash flow make the stock vulnerable even as AI demand holds up. With steep interest costs, a large negative free cash flow hole and rising yields, I’m taking a mid-term short on CRWV and backing Nebius as the better-capitalized neocloud option.
SK hynix is a primary beneficiary if AI-driven demand pushes HBM and high-end DRAM prices materially higher in 2027. With a focused product mix, improving margin profile and significant data-center exposure, the stock is a high-conviction tactical long. Trade plan below includes entry at $95, a conservative stop at $72 and a target of $160 tied to …
StoneX (SNEX) is trading at ~$56 with a P/E in the mid-teens despite improving recurring revenue streams, stronger free cash flow and multiple growth catalysts across payments, FX and commodities. This trade idea lays out a long entry at $56.25, a stop at $50.00 and a target of $70.00 over a long-term (180 trading days) horizon, betting on a valuat…
Netflix sold off after a modest cut to ad guidance and another quarter of decelerating revenue growth. Fundamentals remain solid - Q3 revenue near $12.9B, operating margins in the mid-30s and more than $11B in annual free cash flow - creating an asymmetric trade: limited downside if the ad business stabilizes, meaningful upside if subscriber moneti…
Illumina's sequencing hardware refresh and recurring consumables sales are keeping revenue momentum alive. With a positive earnings surprise signal, heavy short interest and a recent pullback, the stock offers a high-probability tactical long for traders willing to accept valuation and execution risk. Entry $270, stop $250, target $305 over a mid-t…
CarMax (KMX) is showing measurable operational improvement: retail used-unit sales and average selling prices are rising, auto finance income is expanding, SG&A per unit is falling, and management is restarting buybacks. At roughly $51.50 entry, the stock trades at ~P/E 25 and P/B 1.16 with over $1.1B in free cash flow - a setup for asymmetric upsi…
Peabody Energy (BTU) is an industry-leading coal producer trading at a modest multiple relative to peers and history, with a market cap near $2.76B and EV/EBITDA of 9.2. Balance-sheet metrics are tidy and the stock is technically oversold, presenting a risk/reward setup for a position-sized trade. We lay out an actionable plan: buy at $22.50, stop …
SiTime (SITM) is a niche semiconductor company building MEMS-based timing solutions that are now central to AI datacenter and communications infrastructure. Recent results and the Renesas timing-business deal materially accelerate revenue scale; the stock has pulled back from its highs and presents a tradeable long with defined risk controls. This …
Regeneron trades at a mid-teens earnings multiple while growth is accelerating from Dupixent and a differentiated weight‑loss pipeline. With strong free cash flow, low leverage and attractive technical momentum, a tactical long into earnings and upcoming pipeline readouts looks reasonable. Entry $810, stop $760, target $920 over a mid-term 45 tradi…
McKesson (MCK) combines a defensive distribution franchise with a growing technology and specialty-services runway. At roughly $118.7B market cap and $1,017.71 per share, the stock already reflects some optimism. I see a practical trade: long into a 2027 re-rate driven by AI adoption across Prescription Technology Solutions, expanded specialty serv…
Legend Biotech sits between a blockbuster commercial franchise and persistent profitability pressure. Positive clinical readouts and manufacturing investment support upside, but a June underwritten offering, negative PE, and elevated short activity keep the risk elevated. This trade proposes a measured long with a clear stop and a 180-trading-day h…
Netflix reported double-digit revenue growth and expanding margins, yet the stock has been punished after a lowered ad-revenue guide. The business fundamentals and cash generation argue for a tactical long; the trade below balances upside capture with a defined stop to limit execution risk.
Revvity has quietly converted a high-margin diagnostics consumables business into an annuity that funds investments into data and AI products. With a market cap near $17.7B, healthy free cash flow, and recent organic diagnostics strength, I view RVTY as a mid-term long with defined risk controls while the market prices in AI monetization.
Strategy Inc.'s 10.00% Series A perpetual preferred (STRF) trades at about 1.11x mNAV. With management saying it may sell Bitcoin to fund buybacks and preferred payments, the preferred offers a cleaner yield-and-capital-appreciation profile vs. the company deploying new capital into Bitcoin at a premium. This trade plan targets the $111.99 52-week …
Apple (AAPL) is a buy for disciplined portfolios at current levels thanks to $136.7B in free cash flow, a $5.03T market cap, and steady services and hardware cash generation. Valuation is rich (PE ~39, PB ~46.7, EV/EBITDA ~30), so we recommend a tactical long with strict sizing (3% portfolio) and a mid-term horizon to capture post-product-cycle and…
MSCI reported 12.4% revenue growth and beat Q3 estimates, but the shares are priced for perfection. With a market cap near $44B, P/E ~31, EV/EBITDA ~24 and FCF yield around 3.3%, upside is limited versus the downside to a re-rating if growth or margin tailwinds slow. I outline a mid-term short trade (45 trading days) with an entry at $604.71, a $66…
Rigel is morphing from a small clinical-stage biotech into a commercial biotech with multiple near-term revenue drivers. FDA approval and a global licensing deal for VEPPANU, steady rollouts of TAVALISSE in Latin America, and recent revenue beats make a compelling case for a re-rate. The balance sheet, cash flow and cheap valuation (sub-3x reported…
Workiva is executing on margin expansion and organic growth at scale: record operating margins, accelerating revenue (~20% year-over-year), and $200M+ of free cash flow. The stock is still trading below historical multiples. This trade targets a re-rate to a more normalized SaaS multiple as AI adoption and enterprise spend lift ARR trajectory.
Meta's Q3 beat and early Muse traction (10M North American users) mark a structural shift: advertising strength is being complemented by a first meaningful AI revenue engine. Valuation sits at a reasonable multiple given growth and $41B in free cash flow. This trade idea buys a pullback into strength with a long-term horizon and defined stop.
Tenet Healthcare (THC) is showing clearer margin improvement and cash conversion than many expect. With EV/EBITDA at 6.85, P/E near 9.7, and free cash flow roughly $3.0B, the stock can re-rate if Q3 results on 10/29/2026 confirm accelerating operating leverage. This trade targets a measured long into and after the print with tight risk control.
Teledyne's mix of high-margin sensors, aerospace electronics and engineered systems is hitting a sweet spot: strong defense infrared demand, a record $5.3B funded backlog and improving margin dynamics are supporting revenue upgrades. With a $29.2B market cap, healthy cash flow ($1.14B FCF) and modest leverage (debt/equity 0.19), this is an actionab…
Texas Instruments has reported another set of upside results and is showing signs of a broader recovery in its end markets. With free cash flow of $5.36B, a 2% dividend yield, and management signaling a quieter capex profile, the risk/reward looks favorable for a mid-term long trade. Technicals are mixed but improving; valuation is premium, so posi…
Diageo is positioned to benefit from renewed alcohol demand among younger drinkers and the global ready-to-drink cocktail trend. Technicals and consumption signals support a tactical long with a clear entry, stop and target over a 180 trading-day horizon.
